Therapeutic exposure Any level of radiation exposure to the chest, axilla, or TBI Surveillance* Mammography — Yearly, beginning at age 25 yr or 8 yr post-radiation, whichever occurs last Breast MRI — Yearly, as an adjunct to mammography, beginning at age 25 yr or 8 yr post-radiation, whichever occurs last | Therapeutic exposure Any level of radiation exposure to the abdomen, pelvis, spine (lumbar, sacral, whole), TBI Surveillance* Multitarget stool DNA test — performed every 3 yr, beginning at age 30 yr or 5 yr after radiation, whichever occurs last. Positive result should be followed up with a timely colonoscopy Colonoscopy — Performed every 5 yr, beginning at age 30 yr or 5 yr after radiation, whichever occurs last. | Therapeutic exposure Anthracycline chemotherapy or radiation to a field that involves the heart Surveillance* Echocardiogram (or comparable imaging to evaluate cardiac function) starting at the completion of cancer therapy†
Anthracycline dose = none If radiation dose is < 15 Gy or none, then the recommended frequency is “no surveillance” If radiation dose is ≥ 15 to < 35 Gy, then the recommended frequency is every 5 yr If radiation dose is ≥ 35 Gy, then the recommended frequency is every 2 yr. Anthracycline dose ≤ 250 mg/m2 If radiation dose is < 15 Gy or none, then the recommended frequency is every 5 yr If radiation dose is ≥ 15 Gy, then the recommended frequency is every 2 yr. Anthracycline dose is ≥ 250 mg/m2 If radiation dose is “any or none,” then the recommended frequency is every 2 yr
|